Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.
about
Biological markers of amyloid beta-related mechanisms in Alzheimer's diseaseCerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionBrain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALSCSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's diseaseNeurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisComparative analysis of the time-dependent functional and molecular changes in spinal cord degeneration induced by the G93A SOD1 gene mutation and by mechanical compression.Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case reportCerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolismDeath-associated protein kinase 1 has a critical role in aberrant tau protein regulation and function.Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus reportNeuronal Damage Induced by Perinatal Asphyxia Is Attenuated by Postinjury Glutaredoxin-2 AdministrationTumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathyElevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients.CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma.High-resolution nuclear magnetic resonance spectroscopic study of metabolites in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathyMechanisms, models and biomarkers in amyotrophic lateral sclerosisAssociation between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosisQuantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease.Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementiaCerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathyPlasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study.Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament LightNeurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation.Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.CSF neurofilament light chain reflects corticospinal tract degeneration in ALS.Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variantsIncreased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive ImpairmentNeurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.CSF neurofilament proteins in the differential diagnosis of dementiaTau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?
P2860
Q24622136-519B9598-8035-4BD1-9D67-AFFDBEBD2BA4Q24810504-DF9BF4F1-6207-4A47-9531-A4E5A2D1289EQ26799233-346DE6D8-4E61-4AB0-A5ED-780A3B4BE422Q26823418-F8DC9149-FCBD-46F3-AF84-5C767E8C285DQ28481340-C0EB8FF3-08F4-4016-AA7C-4376BF031B47Q28728773-484B6DC0-0DB9-45AF-805B-58A58DDB8020Q30224292-99F47D4A-3121-4E18-AF36-C93036621663Q30484665-DB303776-B332-4B6E-942B-84594167D55AQ33257724-FCE4A77D-EA12-470B-9B75-9E80BF7FF56CQ33610029-D82828EC-272F-4CCE-8F3B-2BAFA49ABB40Q33612995-1673F30A-7DB2-4A30-9206-950C2650C9DEQ33720139-D0A87CE4-30A0-4A4C-B632-3BF98EAEF556Q33721681-A73A1110-8068-4CC0-B5BC-B88576C2FF47Q33863777-54136F3D-F1C7-46CA-94E1-5C9A3560ACE2Q33972343-87484FCC-08E5-4AAF-AC43-4DE0B0E1B104Q34068878-62DF4284-84A2-40E3-8691-4CB2794135FAQ34229877-44D6AB09-87DD-4968-8EE0-1C40E5DEFC7AQ34337808-A18D5216-2650-4BE4-BA65-B6EA45CCA5CEQ34344992-951B648D-3549-4095-A1D4-1704607E82ACQ34427340-08AC4411-5AFB-4F8E-A385-D0B7A8D04A14Q34470414-BA90BFEA-7E2F-4811-A1A7-36DB873A8417Q34714277-4B4201D3-3914-458A-8629-FD7CAA9E315DQ34746995-10CBBB98-40D3-4A6F-8CC5-0CFE80FAF3E9Q34776835-97AEAA36-D1B3-4188-A800-680C82BFDBADQ35000781-03344A7E-EBDA-449E-A466-22C168E95EEFQ35093695-63B739CC-B5EA-493F-B135-7DD6BBE17CFFQ35458189-E5BBE358-7FE8-4723-8F01-ABEAC3672688Q35550715-C36AB0C9-4F25-41E5-A38A-2AEA9F55BEA1Q35587114-2DCF0CA0-7D83-4A85-8742-2308889592AAQ35681358-06BD449C-582D-467B-BF5E-D67A30CA6B7DQ35686186-C7AC5988-A0E6-4D77-A8DE-27F54A2551C0Q35735315-C6711AE1-CD17-41DC-AA01-8B3B6ED5AAFEQ35878624-D5BCF155-66C1-4DB7-977D-5CA3C2D63F4FQ35935100-1C0197BE-0973-44CD-9409-E2508C93129EQ35996619-3CBCEF03-1856-47AB-8EF4-568F16B6EEBAQ35998869-B47FEEA9-5EF0-4B6A-A3D1-96672A51724BQ36050420-C139371A-5E22-4B25-9355-366EC583B6B3Q36161527-E2116FB5-92BB-4EFE-8B87-8AEDBD17F00DQ36227579-E6AEE1A1-C6DF-4823-B037-EC0B16C14E6FQ36291565-07733502-B827-4A27-AC03-3B686FC9416C
P2860
Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Patients with amyotrophic late ...... neurofilament protein in CSF.
@ast
Patients with amyotrophic late ...... neurofilament protein in CSF.
@en
Patients with amyotrophic late ...... neurofilament protein in CSF.
@nl
type
label
Patients with amyotrophic late ...... neurofilament protein in CSF.
@ast
Patients with amyotrophic late ...... neurofilament protein in CSF.
@en
Patients with amyotrophic late ...... neurofilament protein in CSF.
@nl
prefLabel
Patients with amyotrophic late ...... neurofilament protein in CSF.
@ast
Patients with amyotrophic late ...... neurofilament protein in CSF.
@en
Patients with amyotrophic late ...... neurofilament protein in CSF.
@nl
P2093
P921
P1476
Patients with amyotrophic late ...... neurofilament protein in CSF.
@en
P2093
Karlsson JE
Karlsson JO
Persson LI
Wikkelsø C
P304
P407
P577
1996-11-01T00:00:00Z